Reprimo methylation is a potential biomarker of Barrett's-Associated esophageal neoplastic progression.

No abstract available.

Abraham JM, Cheng Y, Greenwald BD, Hamilton JP, Ito T, Jin Z, Kan T, Meltzer SJ, Mori Y, Paun BC, Sato F, Wang S, Yang J

17121882

Clin. Cancer Res., 2006, 12 (22)